STOCK TITAN

Viking Global reports 5.8% Veradermics (MANE) stake after IPO

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Veradermics, Inc. received a new major shareholder disclosure from Viking Global–affiliated funds. The group reports beneficial ownership of 2,151,493 shares of Veradermics common stock, representing 5.8% of the outstanding shares following the company’s initial public offering.

The position is held through two main Cayman Islands limited partnerships: Viking Global Opportunities Illiquid Investments Sub-Master LP with 1,290,896 shares and Viking Global Opportunities Drawdown (Aggregator) LP with 860,597 shares. Various Delaware general partner and management entities, including Viking Global Investors LP and Viking Global Opportunities Parent GP LLC, are listed as having shared voting and dispositive power.

Individuals O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are each reported as beneficial owners of the full 2,151,493 shares through their roles on Viking’s executive committee, with no direct share ownership. The filing certifies that the securities were not acquired to change or influence control of Veradermics.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G



VIKING GLOBAL INVESTORS LP
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of VIKING GLOBAL INVESTORS LP (1)(2)(3)
Date:02/12/2026
Viking Global Opportunities Parent GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Parent GP LLC (1)(2)(3)
Date:02/12/2026
Viking Global Opportunities GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities GP LLC (1)(2)(3)
Date:02/12/2026
Viking Global Opportunities Portfolio GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Portfolio GP LLC (1)(2)(3)
Date:02/12/2026
Viking Global Opportunities Illiquid Investments Sub-Master LP
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Illiquid Investments Sub-Master LP (1)(2)(3)
Date:02/12/2026
Viking Global Opportunities Drawdown GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Drawdown GP LLC (1)(2)(3)
Date:02/12/2026
Viking Global Opportunities Drawdown Portfolio GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Drawdown Portfolio GP LLC (1)(2)(3)
Date:02/12/2026
Viking Global Opportunities Drawdown (Aggregator) LP
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Drawdown (Aggregator) LP (1)(2)(3)
Date:02/12/2026
HALVORSEN OLE ANDREAS
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of O. Andreas Halvorsen (1)
Date:02/12/2026
Ott David C.
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of David C. Ott (2)
Date:02/12/2026
Shabet Rose Sharon
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Rose S. Shabet (3)
Date:02/12/2026

Comments accompanying signature: (1) Scott M. Hendler is signing on behalf of O. Andreas Halvorsen, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, VIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLC, VIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLC and VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Halvorsen on February 12, 2021 (SEC File No. 005-49737). (2) Scott M. Hendler is signing on behalf of David C. Ott, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, VIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLC, VIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLC and VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Halvorsen on February 12, 2021 (SEC File No. 005-49737). (3) Scott M. Hendler is signing on behalf of Rose S. Shabet, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, VIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLC, VIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLC and VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Halvorsen on February 12, 2021 (SEC File No. 005-49737).
Exhibit Information

EXHIBIT A - JOINT FILING AGREEMENT

FAQ

What stake in Veradermics, Inc. (MANE) did Viking Global report on this Schedule 13G?

Viking Global–affiliated entities reported beneficial ownership of 2,151,493 Veradermics common shares, representing 5.8% of the outstanding stock. This disclosure reflects their position following Veradermics’ initial public offering, including the underwriters’ full exercise of their option to purchase additional shares.

How are Viking Global’s Veradermics (MANE) shares split between its investment vehicles?

The filing shows 1,290,896 Veradermics shares directly owned by Viking Global Opportunities Illiquid Investments Sub-Master LP and 860,597 shares directly owned by Viking Global Opportunities Drawdown (Aggregator) LP. Management and voting authority over these holdings is exercised through a series of related Delaware general partner entities.

Which individuals are listed as beneficial owners of Veradermics (MANE) shares in the Viking Global Schedule 13G?

O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are each reported as beneficial owners of 2,151,493 Veradermics shares. They hold shared voting and dispositive power through their roles on Viking’s executive committee, but none directly owns Veradermics common stock personally.

What percentage of Veradermics (MANE) outstanding shares does Viking Global’s 13G filing use for its ownership calculations?

Ownership percentages are based on 37,338,731 Veradermics common shares outstanding after its initial public offering closed on February 5, 2026, including the underwriters’ full exercise of their option. Viking Global’s 2,151,493 shares correspond to 5.8% of this reported share count.

Does Viking Global’s Schedule 13G for Veradermics (MANE) indicate an intent to influence control of the company?

The certification states the securities were not acquired and are not held to change or influence control of Veradermics. It also notes they are not held in connection with any transaction having that purpose or effect, other than activities solely tied to a nomination under Rule 14a-11.

What level of voting and dispositive power does Viking Global report over Veradermics (MANE) shares?

The reporting entities disclose zero sole voting or dispositive power and shared voting and dispositive power over the reported Veradermics shares. For Viking Global Investors LP and several related entities, shared power covers the full 2,151,493 shares held through the underlying limited partnerships.
VERADERMICS INC

NYSE:MANE

View MANE Stock Overview

MANE Rankings

MANE Latest News

MANE Latest SEC Filings

MANE Stock Data

2.37B
15.08M
Biotechnology
Healthcare
Link
United States
New Haven